Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland

Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland

AIM OF THE STUDY In the era of pangenotypic treatment regimens against hepatitis C virus (HCV) infection, data from postmarketing observational studies are crucial to better understand the treatment patterns used in specific countries and treatment outcomes under real-life conditions. We...

Full description

Bibliographic Details
Main Authors: Beat Müllhaupt, David Semela, Lisa Ruckstuhl, Lorenzo Magenta, Olivier Clerc, Ralph Torgler, Francesco Negro, Nasser Semmo
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2021-01-01
Series:Swiss Medical Weekly
Subjects:
chronic hepatitis C
glecaprevir/pibrentasvir
Observational study
real-world
Switzerland
Online Access:https://www.smw.ch/index.php/smw/article/view/2940

Internet

https://www.smw.ch/index.php/smw/article/view/2940

Similar Items